Home688266 • SHA
add
Suzhou Zelgen Biopharmaceuticals Co Ltd
Previous close
¥67.89
Day range
¥64.03 - ¥68.45
Year range
¥33.20 - ¥79.99
Market cap
16.95B CNY
Avg Volume
3.13M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 143.42M | 130.67% |
Operating expense | 171.45M | 3.91% |
Net income | -31.37M | 64.30% |
Net profit margin | -21.87 | 84.52% |
Earnings per share | — | — |
EBITDA | -26.55M | 71.62% |
Effective tax rate | 2.99% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.20B | -0.96% |
Total assets | 2.97B | 3.78% |
Total liabilities | 1.66B | 49.99% |
Total equity | 1.30B | — |
Shares outstanding | 264.71M | — |
Price to book | 13.80 | — |
Return on assets | -3.06% | — |
Return on capital | -3.91% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -31.37M | 64.30% |
Cash from operations | -45.91M | 51.93% |
Cash from investing | -27.13M | -107.95% |
Cash from financing | -122.49M | -232.49% |
Net change in cash | -196.10M | -157.96% |
Free cash flow | 75.31M | 192.20% |
About
Founded
Mar 18, 2009
Website
Employees
858
